Orbit International Corp. reported a net loss of $761,000 for Q3 2026, an improvement from a $875,000 loss in the same period last year, despite a slight increase in adjusted EBITDA loss. Sales rose to $6.16 million, but gross margin declined to 28.7%. For the first nine months, the net loss narrowed to $4.03 million from $4.32 million the prior year, with backlog increasing 20.7% to $14.9 million, the highest since September 2024. The company faces delays in contract awards affecting its Orbit Instrument division but expects improved delivery schedules and bookings in late 2026 and early 2027, supported by stronger performance in its Power Group and Simulator Product Solutions subsidiary.
Orbit International Corp. reported its 2026 Q3 results. For readers following Industrials, here is Pluang's market snapshot as of Nov 12, 2026 19:21 WIB: Among 135 priced US Industrials stocks, 48 rose and 81 fell. AerCap Holdings N.V. shares traded at USD 169.15, down 4.44%, Eos Energy Enterprises Inc at USD 1.91, down 4.02% with 55% buy orders, and Bloom Energy at USD 201.62, down 3.75% with 58% sell orders.
Interlink Electronics announced a 3.4% revenue increase to $3.06 million for Q3 2026 and a 9.6% rise to $9.9 million for the first nine months of 2026, driven by higher shipments of force-sensing and gas-sensor products. The company reported a net lo...
ALS Canada, with renewed funding from TD Bank, is advancing its national strategy for ALS genetics to enhance access to genetic information, counselling, and care for Canadians affected by or at risk of ALS. This builds on the 2024 pilot of the first...
The Canadian ALS Society has renewed funding from TD Bank to expand its national genetics strategy for ALS, improving access to genetic information, counseling, and care for those affected or at risk. This initiative builds on a pilot project that cr...
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
